Fusion Antibodies Plc (FAB.LN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
(Values in thousands)
| 09-2025 | 03-2025 | 09-2024 | 03-2024 | 09-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 252 | 359 | 439 | 1,199 | 487 |
| Inventories | 272 | 269 | 230 | 460 | 524 |
| Other current assets | 868 | 632 | 762 | 603 | 797 |
| TOTAL | $1,392 | $1,260 | $1,431 | $2,262 | $1,808 |
| Non-Current Assets | |||||
| PPE Net | 420 | 63 | 96 | 158 | 250 |
| Other Non-Current Assets | 0 | 0 | 1 | 0 | 0 |
| TOTAL | $420 | $63 | $97 | $158 | $250 |
| Total Assets | $1,812 | $1,323 | $1,528 | $2,420 | $2,058 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 667 | 372 | 417 | 283 | 537 |
| Other current liabilities | N/A | N/A | N/A | 19 | N/A |
| TOTAL | $772 | $623 | $440 | $584 | $554 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 314 | 31 | 29 | 20 | 50 |
| TOTAL | $314 | $31 | $29 | $43 | $50 |
| Total Liabilities | $1,086 | $654 | $469 | $627 | $604 |
| Shareholders' Equity | |||||
| Common Shares | 4,534 | 4,197 | 3,815 | 3,815 | 2,378 |
| Retained earnings | -11,979 | -11,467 | -10,499 | -9,765 | -8,905 |
| TOTAL | $726 | $669 | $1,059 | $1,793 | $1,454 |
| Total Liabilities And Equity | $1,812 | $1,323 | $1,528 | $2,420 | $2,058 |